Upstream Bio, Inc. (UPB) — Financial Flexibility Index
Upstream Bio, Inc. (UPB) has a Financial Flexibility Index of -1.76x as of September 2025. Free cash flow of $-22.19 Million (operating CF $-22.24 Million minus capex $47.00K) represents -2% of total liabilities ($12.61 Million). Also explore net asset momentum of Upstream Bio, Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Upstream Bio, Inc. Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Upstream Bio, Inc. across 3 annual periods. Check Upstream Bio, Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Upstream Bio, Inc. (2022–2024)
Year-by-year free cash flow to debt coverage for Upstream Bio, Inc.. For the full company profile including market capitalisation, see UPB market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.94x | $-58.66 Million | $-59.17 Million | $11.87 Million | ▼ -3044.3% |
| 2023 | -0.16x | $-37.78 Million | $-37.93 Million | $240.32 Million | ▼ -3.5% |
| 2022 | -0.15x | $-18.94 Million | $-19.02 Million | $124.63 Million | — |